Telaprevir (VX-950)

Telaprevir(VX-950)は、C型肝炎ウイルス(HCV)NS3-4Aセリン・プロテアーゼ阻害剤で、IC50 が0.35 μMになる。

目録号S1538
4.5 5 1レビュー 9製品表彰状
価格 在庫  
USD 214 In stock
USD 340 In stock
USD 970 In stock

Telaprevir (VX-950) 化学構造
分子量: 679.85

品質と確認

カスタマーレビュー(1)

Quality Control & MSDS

製品情報

  • Compare HCV Protease Inhibitors
    HCV Protease阻害剤を比較
  • 研究分野

製品の説明

生物活性

情報 Telaprevir(VX-950)は、C型肝炎ウイルス(HCV)NS3-4Aセリン・プロテアーゼ阻害剤で、IC50 が0.35 μMになる。
目標 HCV NS3-4A serine protease
IC50 0.35 μM [1]
In vitro試験 Telaprevir inhibits the hepatitis C virus NS3-4A serine protease, leading to the block of viral polyprotein processing and subsequently decrease of viral RNA replication, total HCV RNA levels and protein levels in the Con1 (genotype 1b) subgenomic HCV replicon cells in a time- and dose-dependent manner. Telaprevir displays a significant time-dependent increase in inhibitory effect on the replication of HCV RNA with IC50 values of 0.574 μM, 0.488 μM, 0.210 μM and 0.139 μM for 24, 48, 72 and 120 hours incubation, respectively. Telaprevir displays an average IC50 of 0.354 μM and an average IC90 of 0.830 μM, respectively, from three independent experiments using the 48 hours incubation. Telaprevir has no significant cytotoxicity to HCV replicon cells, parental Huh-7 and HepG2 cells after 48 hours incubation. Telaprevir (17.5 μM) completely eradicates HCV RNA from replicon cells after 13 days incubation without rebound after Telaprevir is withdrawn. Telaprevir displays an additive to moderate synergistic effect on reduction of HCV RNA replication and suppression of resistance mutations without significant increase in cytotoxicity when in combination with IFN-α, compared to treatment with each agent alone. [1]
In vivo試験 Oral administration of Telaprevir reduces HCV protease-dependent cleavage and subsequent secretion of SEAP from the liver into the blood in the mice model to 18.7% and 18.4% at dosage of 10 and 25 mg/kg, respectively. [2] Administration of Telaprevir at 200 mg/kg for 1 week results in a 1.9 log reduction of HCV RNA in genotype 1b HCV-infected human hepatocyte chimeric mice, and when treatment in combination with MK-0608 (50 mg/kg) for 4 weeks, viruses are eliminated from mice. [3]
臨床試験 Currently in Phase III clinical trials in patients with Hepatitis C.
特集 Telaprevir is a covalent, reversible inhibitor of the NS3-4A protease (unlike BILN 2061which is a noncovalent inhibitor), with a slow-binding and slow-dissociation mechanism.

推薦された実験操作 (公開の文献だけ)

キナーゼアッセイ: [1]

Determination of anti-HCV activity Stable Huh-7 cells containing the self-replicating, subgenomic HCV replicon, which is identical in sequence to the I377neo/NS3-3'/wt replicon are used for anti-HCV assays. Replicon cells are incubated at 37 °C for the indicated period of time with Telaprevir serially diluted in DMEM plus 2% FBS and 0.5% dimethyl sulfoxide (DMSO). Total cellular RNA is extracted using an RNeasy-96 kit, and the copy number of HCV RNA is determined using a quantitative RTPCR (QRT-PCR) assay for the assessment of 50% inhibitory concentration (IC50

細胞アッセイ: [1]

細胞系 Huh-7, HepG2, and peripheral blood mononuclear cells (PBMC)
濃度 Dissolved in DMSO, final concentration ~1 mM
処理時間 48 hours
方法 Cells are incubated with various concentrations of Telaprevir for 48 hours. Cell viability is determined by using a tetrazolium (MTS)-based cell viability assay.

動物実験: [2]

動物モデル SCID mice injected with recombinant adenovirus (Ad-WT-HCVpro-SEAP or Ad-MT-HCVpro-SEAP)
製剤 Formulated in polyvinylpyrrolidone (PVP) K-30 plus 2% sodium lauryl sulfate
投薬量 ~300 mg/kg
管理 Oral gavage
Solubility 30% PEG400/0.5% Tween80/5% propylene glycol 30 mg/mL
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesBaboonDogMonkeyRabbitGuinea pigRatHamsterMouse
Weight (kg)121031.80.40.150.080.02
Body Surface Area (m2)0.60.50.240.150.050.0250.020.007
Km factor202012128653
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

参考

化学情報

Download Telaprevir (VX-950) SDF
分子量 679.85
化学式

C36H53N7O6

CAS No. 402957-28-2
保管 2年-20℃
6月-80℃in DMSO
別名 LY-570310, MP-424
溶解度 (25°C) * In vitro DMSO 136 mg/mL (200 mM)
<1 mg/mL (<1 mM)
エタノール <1 mg/mL (<1 mM)
In vivo 30% PEG400/0.5% Tween80/5% propylene glycol 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
化学名 (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)-octahydrocyclopenta[c]pyrrole-1-carboxamide

研究分野

カスタマーレビュー (1)


Click to enlarge
Rating
Source Dr. Julie Sheldon,Dr Esteban Domingo and Dr Celia Perales. Telaprevir (VX-950) purchased from Selleck
Method MTT assays
Cell Lines
Concentrations 50 μM
Incubation Time 72 h
Results The 50% cytotoxic concentration (CC50) of VX-950 was 22 ± 3.2 μM.

製品表彰状 (9)

技術サポート&よくある質問(FAQ)

顧客がするかもしれない質問に対する答えは、指示を取り扱っている阻害剤で見つかります。話題は、貯蔵液(阻害剤と特別な注意を細胞ベースの分析法と動物のために必要とする問題を保存することは実験します)を準備する方法を含みます。

電話番号: +1-832-582-8158 Ext:3月曜日〜金曜日 9:00 AM–5:00 PM (米国中部標準時)

他の問い合わせをするならば、メッセージを残してください。

* 必須

Related HCVプロテアーゼ 阻害剤

  • E-64

    E-64 is an irreversible and selective cysteine protease inhibitor with IC50 of 9 nM for papain.

  • AEBSF HCl

    AEBSF HCl is a broad spectrum, irreversible serine protease inhibitor.

  • Leupeptin Hemisulfate

    Leupeptin Hemisulfate is a reversible inhibitor of serine and cysteine proteases.

  • Avelestat (AZD9668)

    Avelestat (AZD9668) is an oral, highly selective inhibitor of neutrophil elastase (NE) with IC50 and Ki of 12 nM and 9.4 nM, at least 600-fold more selective over other serine proteases.

  • Danoprevir (ITMN-191)

    Danoprevir (ITMN-191)はB型肝炎ウイルス(HCV)のNS3/4Aプロティナーゼの模擬阻害剤、 IC50 が 0.2-3.5 nM.

    Features:Danoprevir丙型肝炎病毒(HCV)的NS3/4A蛋白酶的模拟抑制剂。

  • Daclatasvir (BMS-790052)

    Daclatasvir (BMS-790052) は一流、高選択性の C型肝炎ウイルス(HCV)阻害剤、EC50 が9–50 pM.

    Features:BMS-790052是一流的高选择性C型肝炎病毒(HCV) NS5A抑制剂, EC50为皮摩尔级。

  • VX-222 (VCH-222, Lomibuvir)

    VX-222 (VCH-222, Lomibuvir)は新型有効と選択の非核苷ポリメラーゼ阻害剤、C型肝炎ウイルス(HCV)RNA依存のRNAポリメラーゼを抑制する時、 IC50 が 0.94-1.2 μMになる.

    Features:VX-222是新型有效和选择性的非核苷聚合酶抑制剂,作用于C型肝炎病毒(HCV) RNA依赖的RNA聚合酶。

  • MG-132

    MG-132は、100nMのIC50によるプロテアソームの強力な阻害剤です。

  • Bortezomib (PS-341)

    Bortezomib (PS-341)は、強力なプロテアソーム阻害剤で、Kiが0.6nMです。

    Features:Bortezomib(Velcade)是有效的蛋白酶抑制剂。

最近見られたアイテム

Tags: Telaprevir (VX-950)を買う | Telaprevir (VX-950)供給者 | Telaprevir (VX-950)を購入する | Telaprevir (VX-950)費用 | Telaprevir (VX-950)生産者 | オーダーTelaprevir (VX-950) | Telaprevir (VX-950)代理店
お問い合わせ